Atopic Dermatitis News

• Parents of Children With AD Suffer Related Sleep Loss A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on sleep aids.
  Medscape Medical News, December 24, 2024
• Self-Guided Online CBT Matches Clinician-Aided CBT for AD Both self-guided and clinician-guided CBT improved eczema scores.
  Medscape Medical News, December 23, 2024
• MSWS 2024 Traditional Hand Eczema Treatments May Face Obsolescence Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.
  Medscape Medical News, December 18, 2024
• Alert FDA Approves Topical Tapinarof for Atopic Dermatitis In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was approximately 80 consecutive days.
  Medscape Medical News, December 16, 2024
• Alert Nemolizumab Gets FDA Nod for Atopic Dermatitis Some patients reported itch relief within a week in clinical trials.
  Medscape Medical News, December 15, 2024
• Childhood Atopic Dermatitis Doesn't Delay Puberty In 'reassuring' findings, children with the skin disease reached various pubertal milestones at almost the same ages as unaffected peers.
  Medscape News UK, November 29, 2024
• Comorbidities of Eczema Are Numerous Those with the skin condition had elevated risk for dozens of other conditions, underscoring the need for multidisciplinary care.
  Medscape News UK, November 15, 2024
• Upadacitinib Effective Long Term for AD in Adolescents An analysis of three phase 3 trials reported relief with upadacitinib through 76 weeks in adolescents with AD.
  Medscape Medical News, October 28, 2024
• Infant's Rash Defies Most Likely Diagnoses The elusive but correct diagnosis proved to be a simple, easily treated condition.
  Medscape News UK, October 25, 2024
• Parent Perceptions Drive Diets of Children With AD Elimination diets offered only mild improvement, and most parents reintroduced foods.
  Medscape Medical News, October 25, 2024
• EADV 2024 Nemolizumab Reassures in Long-Term Atopic Dermatitis Study An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of nemolizumab in patients with moderate to severe AD.
  Medscape Medical News, October 21, 2024
• EADV 2024 No Excess MACE Risk for JAKis in Atopic Dermatitis Analysis Results of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with upadacitinib and abrocitinib for atopic dermatitis.
  Medscape Medical News, October 18, 2024
• EADV 2024 Children With Severe AD Catch Up on Growth With Dupilumab Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on their growth, potentially offering lifelong benefits, according to the results of a study of children aged 6-11 years.
  Medscape Medical News, October 16, 2024
• PCPs Are Key to Halting Atopic March Families rely on PCPs to manage, or ideally prevent, the progression of allergic disorders in young patients.
  Medscape Medical News, October 15, 2024
• Drug Bests Phototherapy for Severe Hand Eczema Alitretinoin netted a greater reduction in severity by 12 weeks, although differences were not significant thereafter.
  Medscape News UK, October 11, 2024
• Hallucinatory Parasitosis: Addressing Both the Skin and Mind A recent review highlighted how dermatologists can guide patients with delusional infestation toward appropriate care without alienating them.
  Medscape News UK, October 11, 2024
• Antibiotics Early in Life Linked to Childhood Atopy Evidence suggested causation in a study that controlled for multiple confounders.
  Medscape News UK, October 10, 2024
• EADV 2024 Late Dupilumab Responders Have Unique Molecular Profile In a major potential step toward personalized therapy for atopic dermatitis, data suggest early, late, and no clinical response to dupilumab can be differentiated on a molecular basis.
  Medscape Medical News, October 09, 2024
• Methotrexate in Atopic Dermatitis: Experts Clarify Dosage Dermatology experts have created key recommendations to guide the standardized use of methotrexate for refractory atopic dermatitis.
  Medscape Medical News, October 09, 2024
• EADV 2024 Hand Eczema: Delgocitinib Takes on Established Treatments Topical delgocitinib appears more effective than oral alitretinoin and is comparable to dupilumab for treating types of hand eczema, according to two separate studies.
  Medscape Medical News, October 08, 2024